Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Atlassian
TEAM
|
+$437M |
| 2 |
AbbVie
ABBV
|
+$380M |
| 3 |
Workday
WDAY
|
+$366M |
| 4 |
Synopsys
SNPS
|
+$323M |
| 5 |
Advanced Micro Devices
AMD
|
+$286M |
Top Sells
| 1 |
Adobe
ADBE
|
+$1.71B |
| 2 |
Apple
AAPL
|
+$984M |
| 3 |
Boston Scientific
BSX
|
+$642M |
| 4 |
Microsoft
MSFT
|
+$599M |
| 5 |
Texas Instruments
TXN
|
+$491M |
Sector Composition
| 1 | Technology | 31.62% |
| 2 | Healthcare | 18.99% |
| 3 | Consumer Discretionary | 10.82% |
| 4 | Financials | 10.24% |
| 5 | Industrials | 8.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
DICE
601
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $34.6M | 0.02% |
1,806,918
-32,311
| -2% | -$618K |
|
602
Charter Communications
CHTR
$35.9B
| $34.4M | 0.02% |
63,082
-16,210
| -20% | -$8.84M |
|
603
Criteo
CRTO
$1.18B
| $34.3M | 0.02% |
1,257,525
+103,642
| +9% | +$2.83M |
|
604
Reinsurance Group of America
RGA
$12.7B
| $34.2M | 0.02% |
312,669
+71,990
| +30% | +$7.88M |
|
605
Ally Financial
ALLY
$12.7B
| $34.1M | 0.02% |
784,842
-340,909
| -30% | -$14.8M |
|
|
SAGE
606
DELISTED
Sage Therapeutics
SAGE
| $34.1M | 0.02% |
1,029,953
+54,971
| +6% | +$1.82M |
|
607
Live Nation Entertainment
LYV
$39.6B
| $34.1M | 0.02% |
289,599
-97,298
| -25% | -$11.4M |
|
|
TWTR
608
DELISTED
Twitter, Inc.
TWTR
| $34M | 0.02% |
879,584
-651,255
| -43% | -$25.2M |
|
609
Praxis Precision Medicines
PRAX
$847M
| $34M | 0.02% |
222,263
-575
| -0.3% | -$88K |
|
610
Rush Street Interactive
RSI
$2.01B
| $34M | 0.02% |
4,676,968
+479,183
| +11% | +$3.48M |
|
611
Rhythm Pharmaceuticals
RYTM
$6.66B
| $34M | 0.02% |
2,951,002
-182,933
| -6% | -$2.11M |
|
612
Health Catalyst
HCAT
$229M
| $33.9M | 0.02% |
1,297,867
-80,512
| -6% | -$2.1M |
|
613
Fulton Financial
FULT
$3.51B
| $33.9M | 0.02% |
2,037,041
-204,902
| -9% | -$3.41M |
|
614
Datadog
DDOG
$48.5B
| $33.8M | 0.02% |
223,052
+174,414
| +359% | +$26.4M |
|
615
World Kinect Corp
WKC
$1.41B
| $33.8M | 0.02% |
1,249,204
-497,450
| -28% | -$13.5M |
|
616
Arrowhead Research
ARWR
$3.99B
| $33.6M | 0.02% |
731,564
-235,121
| -24% | -$10.8M |
|
617
Janus Henderson AAA CLO ETF
JAAA
$25B
| $33.6M | 0.02% |
669,610
+628,368
| +1,524% | +$31.5M |
|
618
Purple Innovation
PRPL
$116M
| $33.6M | 0.02% |
5,739,284
+1,324,034
| +30% | +$7.75M |
|
619
Janux Therapeutics
JANX
$1.46B
| $33.5M | 0.02% |
2,339,146
-61,747
| -3% | -$885K |
|
|
HEES
620
DELISTED
H&E Equipment Services
HEES
| $33.5M | 0.02% |
769,238
-754,530
| -50% | -$32.8M |
|
|
ECOM
621
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $32.8M | 0.02% |
1,979,182
-211,611
| -10% | -$3.51M |
|
622
Emergent Biosolutions
EBS
$425M
| $32.6M | 0.02% |
793,332
-1,029,549
| -56% | -$42.3M |
|
623
DaVita
DVA
$9.46B
| $32.5M | 0.02% |
287,397
-36,586
| -11% | -$4.14M |
|
624
Korn Ferry
KFY
$3.81B
| $32.4M | 0.02% |
499,341
-204,724
| -29% | -$13.3M |
|
625
Associated Banc-Corp
ASB
$4.36B
| $32.3M | 0.02% |
1,420,180
-66,395
| -4% | -$1.51M |
|